New App detects dementia risks early
• Early stages are reliably detected, before the brain damage becomes irreversible.
• Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%).
• Now available for free during pre-launch.
Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today there is no effective therapy for advanced stages of dementia.
Therefore, effective screening tests are needed to detect early stages reliably, and to start treatment before the brain damages become irreversible.
A group of physicians has therefore developed a simple test - the DST - Dementia Screening Test. The reliability of the test results has been confirmed in clinical studies, and the test has therefore been recognized as a medical device by the competent authorities throughout the EU, Switzerland, Iceland, Norway, Liechtenstein, New Zealand, Canada and Australia.
Since 10 Dec 2018, the DST is now available as an App for any standard smartphone or tablet. So it can be performed easily and quickly at home. The app identifies the individual dementia risk, provides recommendations for reducing the risk, and documents changes over time.
The developers put great emphasize on reliable results, ease of use, and complete data security. No registration is required, no personal information is collected, and the test results are stored only on the tablet or smartphone used, but not on a central server. Of course, an overview of the results can be exported and thus presented to a physician to discuss further diagnostic and / or therapeutic measures before the brain damage becomes irreversible
Dr. Horn is Medical Doctor with a special passion for adressing unmet medical needs of the future.
Contact for questions
Dr. med. Sebastian Horn
Friedrichstr. 67, 10117 Berlin, Germany
T. 0152 - 55834551
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New App detects dementia risks early here
News-ID: 1429758 • Views: 289
More Releases from DST
Dementia screening and prevention – hope or hype?
It is estimated that about 50% of dementia patients do not receive a formal diagnosis. And when the diagnosis is made, it often happens at a time when the disease is well advanced and brain damages are irreversible. A major reason for this is that systematic dementia screening and prevention programmes are not yet ready for implementation as large-scale public health interventions. A key reason for this is the desire
Dementia begins in the mid-40s - early detection crucial
We know today that those who will probably be demented in 15 to 20 years are already experiencing their first brain changes today. In other words, in many people it is already clear at the age of 40 to 50 whether they start to develop dementia. Fortunately, our brain can compensate individual deficits so well for 15 to 20 years that the affected person and the environment do not notice
Dementia test predicts disease 18 years before symptoms
• Multi-dimensional cognitive tests detect restrictions at least 18 years prior to clinical Dementia symptoms. • Good therapy options exist for this pre-symptomatic phase. It has been known for several years that cognitive tests can "predict" dementia 10-12 years prior to clinical symptoms - or more precisely: they can recognize initial limitations in people who are not clinically conspicuous / symptomatic in everyday life, but who are later diagnosed with dementia. The
Early Dementia detection via App receives medical device status
- The DST (Dementia Screening Test) App has been recognized by Health Authorities as a Medical Device. - Early Dementia stages are reliably detected, before the brain damages become irreversible. - Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%). Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today, there is no effective therapy for advanced stages of dementia. Therefore, effective screening
More Releases for Medical
Medical Tourism Business
Medical Tourism businesses are experiencing sudden whoop in the industry. It is because of the availability of great procedures, technologies, infrastructure, and medicines required. It is projected that the Medical Tourism sector will progress to $8.2-9 Billion by 2025. In the market data, it clearly shows, the demand for healthcare services is rapidly growing, and it is potential for the business to enter the market. As the modern trends, awareness,
Asynchronizer：External defibrillator Charging time：At 360J less than 10 sec Paddle configuration：Reusable extermal adult and pediatric paddles Operates from the mains (AC) and with its intemal Lead-acid battery Jiangsu Medwish Network Technology Co., Ltd. is located in Jiangsu, China. It is in a beautiful, clean and convenient environment. We are a professional manufacturer engaged in the research, development, production, sales and export of medical equipment. At the same time, we have a professional foreign
Global Embolization Particle Market 2019 - Sirtex Medical, Merit Medical, Cook M …
The global "Embolization Particle Market" report delivers a comprehensive and systematic framework of the Embolization Particle market at a global level that includes all the key aspects related to it. The data is collected from different sources allied to the global Embolization Particle market and the research team meticulously analyze the gathered data with the help of various analytical tools and present their opinion based on analysis and calculations. The
Global Tracheostomy Tube (Tracheotomy Tube) Market 2018 - Medtronic, Teleflex Me …
The Global Tracheostomy Tube (Tracheotomy Tube) Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Tracheostomy Tube (Tracheotomy Tube) industry. Firstly, Tracheostomy Tube (Tracheotomy Tube) Market report provides a basic overview of the Tracheostomy Tube (Tracheotomy Tube) industry including definitions, classifications, applications and Tracheostomy Tube (Tracheotomy Tube) industry chain structure. Global Tracheostomy Tube (Tracheotomy Tube) Market analysis is provided for the international market
Medical Power Market Medical Power Market
This report studies Medical Power in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Request for discount @ https://www.researchtrades.com/discount/1445183 This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Astrodyne TDI (US) CUI Inc. (US) Delta Electronic, Inc (TW) Excelsys
Medical Ventilators – Medical Devices Pipeline Assessment, 2017
ReportBazzar has released its latest research-based report entitled ‘Medical Ventilators’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Medical Ventilators market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Medical Ventilators market growth. It takes into account aspects such as drivers, restraints, challenges, and